The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Stealth nanoparticles in oncology: Facing the PEG dilemma
Open accessAbstract
Nanoparticles (Nps) have revolutionized the landscape of many treatments, by modifying not only pharmacokinetic properties of the encapsulated agent, but also providing a significant protection of the drug from non-desired interactions, and reducing side-effects of the enclosed therapeutic, enabling co-encapsulation of possibly synergistic compounds or activities, allowing a controlled release of content and improving the therapeutic effect. Nevertheless, in systemic circulation, Nps suffer a rapid removal by opsonisation and the action of Mononuclear phagocyte system (MPS). To overcome this problem, different polymers, in particular Polyethyleneglycol (PEG), have been used to cover the surface of these nanocarriers forming a hydrophilic layer that allows the delay of the removal. These advantages contrast with some drawbacks such as the difficulty to interact with cell membranes and the development of immunological reactions, conforming the known, "PEG dilemma". To address and minimize this phenomenon, different strategies have been applied. Therefore, this review aims to summarize the state of the art of Pegylation strategies, comment in depth on the principal characteristics of PEG and describe the main alternatives, which are the use of cleavable PEG, addition of different polymers or even use other derivatives of cell membranes to camouflage Nps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Jiang, S., & Cao, Z. (2010) · Advanced Materials · doi:10.1002/adma.200901407 · Cited by 2,027
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizon, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,131
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
Zwitteration: Coating Surfaces with Zwitterionic Functionality to Reduce Nonspecific Adsorption
Schlenoff, J. B. (2014) · Langmuir · doi:10.1021/la500057j · Cited by 951
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Pelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696
Xia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Anticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 630
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake
Ritz, S., Schöttler, S., Kotman, N., Baier, G., Musyanovych, A., Kuharev, J., Landfester, K., Schild, H., Jahn, O., Tenzer, S., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00108 · Cited by 619
The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
Smith, S. A., Selby, L. I., Johnston, A. P. R., & Such, G. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00732 · Cited by 612
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Nanopharmaceuticals (part 1): products on the market
Weissig, V., Pettinger, T., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591
In Vivo Biodistribution of Nanoparticles
Almeida, J. P. M., Chen, A. L., Foster, A., & Drezek, R. (2011) · Nanomedicine · doi:10.2217/nnm.11.79 · Cited by 583
Pozzi, D., Colapicchioni, V., Caracciolo, G., Piovesana, S., Capriotti, A. L., Palchetti, S., De Grossi, S., Riccioli, A., Amenitsch, H., & Laganà, A. (2014) · Nanoscale · doi:10.1039/c3nr05559k · Cited by 581
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Sheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
Chemistry of polyethylene glycol conjugates with biologically active molecules
Zalipsky, S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00023-z · Cited by 552
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
PEGylated liposomes: immunological responses
Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 523
Hatakeyama, H., Akita, H., & Harashima, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00059 · Cited by 495
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Gabizon, A., & Martin, F. (1997) · Drugs · doi:10.2165/00003495-199700544-00005 · Cited by 478
Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant Conjugates
Zalipsky, S. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00032a002 · Cited by 470
Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes
Gao, W., Hu, C. J., Fang, R. H., Luk, B. T., Su, J., & Zhang, L. (2013) · Advanced Materials · doi:10.1002/adma.201300638 · Cited by 465
Cole, M. A., Voelcker, N. H., Thissen, H., & Griesser, H. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.026 · Cited by 454
Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona
Caracciolo, G., Farokhzad, O. C., & Mahmoudi, M. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.011 · Cited by 426
Muhamad, N., Plengsuriyakarn, T., & Na-Bangchang, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165210 · Cited by 410
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
Fang, Y., Xue, J., Gao, S., Lu, A., Yang, D., Jiang, H., He, Y., & Shi, K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1388451 · Cited by 386
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Kroll, A. V., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00569 · Cited by 379
Dias, A. M. G. C., Hussain, A., Marcos, A. S., & Roque, A. C. A. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.10.003 · Cited by 376
Wang, T., Bai, J., Jiang, X., & Nienhaus, G. U. (2012) · ACS Nano · doi:10.1021/nn203892h · Cited by 362
Woodle, M. C., Engbers, C. M., & Zalipsky, S. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00030a001 · Cited by 361
Zhu, L., Wang, T., Perche, F., Taigind, A., & Torchilin, V. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304987110 · Cited by 358
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M. (2018) · Small Methods · doi:10.1002/smtd.201700375 · Cited by 332
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Lu, Y., Yue, Z., Xie, J., Wang, W., Zhu, H., Zhang, E., & Cao, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0234-x · Cited by 313
Hansen, C. B., Kao, G. Y., Moase, E. H., Zalipsky, S., & Allen, T. M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00138-s · Cited by 309
Li, B., Jain, P., Ma, J., Smith, J. K., Yuan, Z., Hung, H.-C., He, Y., Lin, X., Wu, K., Pfaendtner, J., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9562 · Cited by 295
Rafiei, P., & Haddadi, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121881 · Cited by 284
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy
Dash, P., Piras, A. M., & Dash, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.012 · Cited by 260
Targeted anticancer therapy: Overexpressed receptors and nanotechnology
Akhtar, M. J., Ahamed, M., Alhadlaq, H. A., Alrokayan, S. A., & Kumar, S. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.05.004 · Cited by 255
Johnsson, M., & Edwards, K. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74798-5 · Cited by 252
Small and Stable Sulfobetaine Zwitterionic Quantum Dots for Functional Live-Cell Imaging
Muro, E., Pons, T., Lequeux, N., Fragola, A., Sanson, N., Lenkei, Z., & Dubertret, B. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1005493 · Cited by 247
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo
Torchilin, V. P., Shtilman, M. I., Trubetskoy, V. S., Whiteman, K., & Milstein, A. M. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90025-6 · Cited by 239
Wei, Y., Quan, L., Zhou, C., & Zhan, Q. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0040 · Cited by 234
The protein corona of circulating PEGylated liposomes
Palchetti, S., Colapicchioni, V., Digiacomo, L., Caracciolo, G., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.012 · Cited by 233
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 232
Schubert, J., & Chanana, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180601101859 · Cited by 232
Role of Nanotechnology in Pharmaceutical Product Development
Devalapally, H., Chakilam, A., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20875 · Cited by 230
Kale, A. A., & Torchilin, V. P. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060228x · Cited by 228
Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z., Ansell, S., Hope, M. J., & Mui, B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 228
Hatakeyama, H., Akita, H., Ito, E., Hayashi, Y., Oishi, M., Nagasaki, Y., Danev, R., Nagayama, K., Kaji, N., Kikuchi, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.045 · Cited by 216
Interactions between Biomolecules and Zwitterionic Moieties: A Review
Erfani, A., Seaberg, J., Aichele, C. P., & Ramsey, J. D. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00497 · Cited by 215
Amphiphilic poly-N-vinylpyrrolidones:
Torchilin, V. P., Levchenko, T. S., Whiteman, K. R., Yaroslavov, A. A., Tsatsakis, A. M., Rizos, A. K., Michailova, E. V., & Shtilman, M. I. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00050-3 · Cited by 214
Kierstead, P. H., Okochi, H., Venditto, V. J., Chuong, T. C., Kivimae, S., Fréchet, J. M. J., & Szoka, F. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.023 · Cited by 210
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Eloy, J. O., Petrilli, R., Trevizan, L. N. F., & Chorilli, M. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.085 · Cited by 209
Shin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 208
Kirpotin, D., Hong, K., Mullah, N., Papahadjopoulos, D., & Zalipsky, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00521-2 · Cited by 206
Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2013) · ACS Nano · doi:10.1021/nn305663e · Cited by 205
Hak, S., Helgesen, E., Hektoen, H. H., Huuse, E. M., Jarzyna, P. A., Mulder, W. J. M., Haraldseth, O., & Davies, C. D. L. (2012) · ACS Nano · doi:10.1021/nn301630n · Cited by 204
PEGylation of Nanocarrier Drug Delivery Systems: State of the Art
Howard, M. D., Jay, M., Dziubla, T. D., & Lu, X. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.021 · Cited by 202
Ogawara, K.-I., Furumoto, K., Nagayama, S., Minato, K., Higaki, K., Kai, T., & Kimura, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.028 · Cited by 195
Endosomal Escape: A Bottleneck in Intracellular Delivery
Shete, H. K., Prabhu, R. H., & Patravale, V. B. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9082 · Cited by 194
Yang, W., Liu, S., Bai, T., Keefe, A. J., Zhang, L., Ella-Menye, J.-R., Li, Y., & Jiang, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.02.004 · Cited by 181
Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics
Vijayan, V., Uthaman, S., & Park, I.-K. (2018) · Polymers · doi:10.3390/polym10090983 · Cited by 178
Seynhaeve, A. L. B., Dicheva, B. M., Hoving, S., Koning, G. A., & ten Hagen, T. L. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.034 · Cited by 177
Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake
Zou, Y., Ito, S., Yoshino, F., Suzuki, Y., Zhao, L., & Komatsu, N. (2020) · ACS Nano · doi:10.1021/acsnano.0c02289 · Cited by 174
Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., Mizushima, Y., & Mizushima, T. (2010) · Biomacromolecules · doi:10.1021/bm100754e · Cited by 166
Dawidczyk, C. M., Russell, L. M., & Searson, P. C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00069 · Cited by 164
Juang, V., Chang, C., Wang, C., Wang, H., & Lo, Y. (2019) · Small · doi:10.1002/smll.201903296 · Cited by 164
Phase separation of non-ionic surfactant solutions. A treatment of the micellar interaction and form
Kjellander, R. (1982) · Journal of the Chemical Society, Faraday Transactions 2 · doi:10.1039/f29827802025 · Cited by 162
Cell Membrane-Coated Nanoparticles: Research Advances
Zou, S., Wang, B., Wang, C., Wang, Q., & Zhang, L. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0388 · Cited by 160
Masson, C., Garinot, M., Mignet, N., Wetzer, B., Mailhe, P., Scherman, D., & Bessodes, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.016 · Cited by 152
Metselaar, J. M., de Bruin, P., de Boer, L. W. T., de Vringer, T., Snel, C. J., Oussoren, C., Wauben, M. H. M., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340363 · Cited by 150
Shi, F., Wasungu, L., Nomden, A., Stuart, M. C. A., Polushkin, E., Engberts, J. B. F. N., & Hoekstra, D. (2002) · Biochemical Journal · doi:10.1042/bj20020590 · Cited by 149
Finsinger, D., Remy, J.-S., Erbacher, P., Koch, C., & Plank, C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301227 · Cited by 148
Remaut, K., Lucas, B., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.029 · Cited by 146
A pH-Responsive Detachable PEG Shielding Strategy for Gene Delivery System in Cancer Therapy
Guan, X., Guo, Z., Wang, T., Lin, L., Chen, J., Tian, H., & Chen, X. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00080 · Cited by 144
Saadati, R., Dadashzadeh, S., Abbasian, Z., & Soleimanjahi, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0934-y · Cited by 142
Lila, A. S. A., Nawata, K., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.059 · Cited by 141
Mross, K. B., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R. K., & Swenson, C. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0825-y · Cited by 137
Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFR
Pan, X., Wu, G. J., Yang, W., Barth, R. F., Tjarks, W., & Lee, R. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060174r · Cited by 134
Surface Functionalization of Silica Nanoparticles with Cysteine: A Low-Fouling Zwitterionic Surface
Rosen, J. E., & Gu, F. (2011) · Langmuir · doi:10.1021/la201940r · Cited by 134
Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy
Wu, M., Le, W., Mei, T., Wang, Y., Chen, B., Liu, Z., & Xue, C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200284 · Cited by 131
Matrix metalloproteinase 2-responsive micelle for siRNA delivery
Wang, H., Yang, X., Sun, C., Mao, C., Zhu, Y., & Wang, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.050 · Cited by 130
Application of liposomal technologies for delivery of platinum analogs in oncology
Wang, A. Z., Lin, W., Liu, D., & He, C. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38354 · Cited by 130
Superhydrophilic Zwitterionic Polymers Stabilize Liposomes
Cao, Z., Zhang, L., & Jiang, S. (2012) · Langmuir · doi:10.1021/la302433a · Cited by 126
Lee, H., & Larson, R. G. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00146 · Cited by 124
Li, D., Ma, Y., Du, J., Tao, W., Du, X., Yang, X., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b05396 · Cited by 123
Deshpande, M. C., Davies, M. C., Garnett, M. C., Williams, P. M., Armitage, D., Bailey, L., Vamvakaki, M., Armes, S. P., & Stolnik, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.019 · Cited by 121
Xu, H., Wang, K. Q., Deng, Y. H., & Chen, D. W. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.049 · Cited by 120
Targetability of novel immunoliposomes prepared by a new antibody conjugation technique
Bendas, G., Krause, A., Bakowsky, U., Vogel, J., & Rothe, U. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00002-2 · Cited by 119
Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers
Kaneti, L., Bronshtein, T., Dayan, N. M., Kovregina, I., Letko-Khait, N., Lupu-Haber, Y., Fliman, M., Schoen, B., Kaneti, G., & Machluf, M. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b04237 · Cited by 119
Zhang, X., Zhao, M., Cao, N., Qin, W., Zhao, M., Wu, J., & Lin, D. (2020) · Biomaterials Science · doi:10.1039/c9bm01927h · Cited by 118
Li, J., Sun, C., Tao, W., Cao, Z., Qian, H., Yang, X., & Wang, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.015 · Cited by 115
Zhou, W., Shao, J., Jin, Q., Wei, Q., Tang, J., & Ji, J. (2010) · Chemical Communications · doi:10.1039/b915125g · Cited by 111
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
Timaner, M., Letko-Khait, N., Kotsofruk, R., Benguigui, M., Beyar‐Katz, O., Rachman-Tzemah, C., Raviv, Z., Bronshtein, T., Machluf, M., & Shaked, Y. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1547 · Cited by 111
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.
Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107
Bedu-Addo, F. K., Tang, P. S., Xu, Y., & Huang, L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091314940 · Cited by 106
Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Xu, C., Zhang, H., Sun, C., Liu, Y., Shen, S., Yang, X., Zhu, Y., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.031 · Cited by 106
Tagami, T., Uehara, Y., Moriyoshi, N., Ishida, T., & Kiwada, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.013 · Cited by 104
Zhong, L., Xu, L., Liu, Y., Li, Q., Zhao, D., Li, Z., Zhang, H., Zhang, H., Kan, Q., Wang, Y., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.006 · Cited by 104
Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes
Son, K., Ueda, M., Taguchi, K., Maruyama, T., Takeoka, S., & Ito, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.022 · Cited by 102
Immunoliposomes in clinical oncology: State of the art and future perspectives
Merino, M., Zalba, S., & Garrido, M. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.015 · Cited by 101
Self-citationWeber, C., Voigt, M., Simon, J., Danner, A., Frey, H., Mailänder, V., Helm, M., Morsbach, S., & Landfester, K. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00539 · Cited by 101
Implications of nanotechnology for the treatment of cancer: Recent advances
Klochkov, S. G., Неганова, М. Е., Nikolenko, V. N., Chen, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.028 · Cited by 100
Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95
Interactions between pH-sensitive liposomes and model membranes
Bergstrand, N., Arfvidsson, M. C., Kim, J.-M., Thompson, D. H., & Edwards, K. (2003) · Biophysical Chemistry · doi:10.1016/s0301-4622(03)00011-5 · Cited by 95
Poly(Sarcosine) Surface Modification Imparts Stealth‐Like Properties to Liposomes
Bleher, S., Buck, J., Muhl, C., Sieber, S., Barnert, S., Witzigmann, D., Huwyler, J., Barz, M., & Süss, R. (2019) · Small · doi:10.1002/smll.201904716 · Cited by 94
POLY(HPMA)-COATED LIPOSOMES DEMONSTRATE PROLONGED CIRCULATION IN MICE
Whiteman, K. R., Šubr, V., Ulbrich, K., & Torchilin, V. P. (2001) · Journal of Liposome Research · doi:10.1081/lpr-100108459 · Cited by 93
Mashreghi, M., Zamani, P., Moosavian, S. A., & Jaafari, M. R. (2020) · Nanoscale Research Letters · doi:10.1186/s11671-020-03334-9 · Cited by 89
Murthy, A. K., Stover, R. J., Hardin, W. G., Schramm, R., Nie, G. D., Gourisankar, S. P., Truskett, T. M., Sokolov, K., & Johnston, K. P. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400701c · Cited by 85
Clinical developments of antitumor polymer therapeutics
Parveen, S., Arjmand, F., & Tabassum, S. (2019) · RSC Advances · doi:10.1039/c9ra04358f · Cited by 84
Shen, Z., Ye, H., Kröger, M., & Li, Y. (2018) · Nanoscale · doi:10.1039/c7nr09011k · Cited by 83
The hard protein corona of stealth liposomes is sparse
Kristensen, K., Engel, T. B., Stensballe, A., Simonsen, J. B., & Andresen, T. L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.042 · Cited by 79
Hofmann, A. M., Wurm, F. R., Huehn, E., Nawroth, T., Langguth, P., & Frey, H. (2010) · Biomacromolecules · doi:10.1021/bm901123j · Cited by 78
Kanamala, M., Palmer, B. D., Jamieson, S. M. F., Wilson, W. R., & Wu, Z. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0510 · Cited by 76
The early days of PEG and PEGylation (1970s–1990s)
Hoffman, A. S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.05.029 · Cited by 74
Xie, Y., Ding, Y., Sun, D., Wang, G., Hongge, Y., Xu, H., Wang, Z., & Chen, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92519 · Cited by 71
Hashimoto, Y., Shimizu, T., Lila, A. S. A., Ishida, T., & Kiwada, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00653 · Cited by 66
pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes
Auguste, D. T., Armes, S. P., Brzezinska, K. R., Deming, T. J., Kohn, J., & Prud’homme, R. K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.08.036 · Cited by 64
Maeda, T., & Fujimoto, K. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.02.006 · Cited by 63
Long Circulating liposomes: Challenges and Opportunities
Deodhar, S., & Dash, A. K. (2018) · Therapeutic Delivery · doi:10.4155/tde-2018-0035 · Cited by 62
Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
Mima, Y., Lila, A. S. A., Shimizu, T., Ukawa, M., Ando, H., Kurata, Y., & Ishida, T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.040 · Cited by 61
Structural basis of polyethylene glycol recognition by antibody
Lee, C., Su, Y.-C., Ko, T., Lin, L., Yang, C.-Y., Chang, S. S.-C., Roffler, S. R., & Wang, A. H. ‐. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0589-7 · Cited by 61
Rejman, J., Wagenaar, A., Engberts, J. B. F. N., & Hoekstra, D. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2003.10.011 · Cited by 59
PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy
Li, Y., Zhang, T., Liu, Q., & He, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00808 · Cited by 59
Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology
Rodallec, A., Benzekry, S., Lacarelle, B., Ciccolini, J., & Fanciullino, R. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.008 · Cited by 58
Nanodrugs used in cancer therapy
Kopečková, K., Eckschlager, T., Širc, J., Hobzová, R., Plch, J., Hraběta, J., & Michálek, J. (2019) · Biomedical Papers · doi:10.5507/bp.2019.010 · Cited by 58
Merino, M., Lozano, T., Casares, N., Lana, H., Trocóniz, I. F., ten Hagen, T. L. M., Kochan, G. T., Berraondo, P., Zalba, S., & Garrido, M. J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00846-z · Cited by 57
Self-citationArturson, P., Laakso, T., & Edman, P. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721213 · Cited by 56
Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy
Reuven, E. M., Ben‐Arye, S. L., Yu, H., Duchi, R., Perota, A., Conchon, S., Abramovitch, S., Soulillou, J., Galli, C., Chen, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07241 · Cited by 55
Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry
Hayat, S. M. G., Bianconi, V., Pirro, M., & Sahebkar, A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118628 · Cited by 55
Lipoplatin Treatment in Lung and Breast Cancer
Fantini, M., Gianni, L., Santelmo, C., Drudi, F., Castellani, C., Affatato, A. A., Nicolini, M., & Ravaioli, A. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/125192 · Cited by 53
Chen, Y., Xu, Z., Zhu, D., Tao, X., Gao, Y., Zhu, H., Mao, Z., & Ling, J. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.08.038 · Cited by 53
Lila, A. S. A., Uehara, Y., Ishida, T., & Kiwada, H. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23823 · Cited by 51
Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells
Peeters, L., Sanders, N. N., Jones, A. T., Demeester, J., & Smedt, S. C. D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.033 · Cited by 50
Bolkestein, M., de Blois, E., Koelewijn, S. J., Eggermont, A. M. M., Grosveld, F. G., de Jong, M., & Koning, G. A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166173 · Cited by 50
Factors Influencing in Vivo Disposition of Polymeric Micelles on Multiple Administrations
Hara, E., Ueda, M., Makino, A., Hara, I., Ozeki, E., & Kimura, S. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500112u · Cited by 49
Hashiba, K., Sato, Y., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.046 · Cited by 49
Samkange, T., D’Souza, S., Obikeze, K., & Dube, A. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13147 · Cited by 48
Zumaya, A. L. V., Rimpelová, S., Štějdířová, M., Ulbrich, P., Vilčáková, J., & Hassouna, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031200 · Cited by 44
Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
Xiong, W. H., Guo, Z., Zeng, B., Wang, T., Zeng, X., Cao, W., & Lian, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.847901 · Cited by 40
Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency
Dawidczyk, C. M., Russell, L. M., Hultz, M., & Searson, P. C. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.008 · Cited by 39
Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo
Chen, W., Yang, S.-D., Li, F., Qu, C., Liu, Y., Wang, Y., Wang, D., & Zhang, X. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.040 · Cited by 33
Allison, S. J., & Milner, J. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.68 · Cited by 31
Construction of anti-EGFR immunoliposomes via folate–folate binding protein affinity
Pan, X., & Lee, R. J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.007 · Cited by 30
Shah, V. M., Nguyen, D. X., Fatease, A. M. A., Bracha, S., & Alani, A. W. G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.022 · Cited by 27
Tang, J., Zhang, L., Fu, H., Kuang, Q., Gao, H., Zhang, Z., & He, Q. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.12.004 · Cited by 26
Tang, J., Fu, H., Kuang, Q., Zhang, L., Zhang, Q., Liu, Y., Ran, R., Gao, H., Zhang, Z., & He, Q. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.875029 · Cited by 26
EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model
Zalba, S., Contreras, A. M., Merino, M., Navarro, I., de Ilarduya, C. T., Trocóniz, I. F., Koning, G., & Garrido, M. J. (2016) · Nanomedicine · doi:10.2217/nnm.15.208 · Cited by 26
Self-citationTreatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases
Tripathy, D., Tolaney, S. M., Seidman, A. D., Anders, C. K., Ibrahim, N. K., Rugo, H. S., Twelves, C., Dieras, V. C., Müller, V., Du, Y., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.0514 · Cited by 25
Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor
Yang, S.-D., Wang, Y., Ren, Z., Chen, M., Chen, W., & Zhang, X. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.08.079 · Cited by 22
Wróblewska, A. M., Milewska, A., Drozd, M., & Matczuk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042324 · Cited by 21
Wang, T., Chen, Q., Lu, H., Li, W., Li, Z., Ma, J., & Gao, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00355 · Cited by 19
Su, Y., Wang, L., Liang, K., Liu, M., Liu, X., Song, Y., & Deng, Y. (2017) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2017.07.003 · Cited by 18
Kuo, P.-H., Teng, Y.-H., Cin, A.-L., Han, W., Huang, P.-W., Wang, L. H.-C., Chou, Y., Yang, J., Tseng, Y., Kao, M.-H., et al. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1745326 · Cited by 14
Platinum-Based Antitumor Drugs and Their Liposomal Formulations in Clinical Trials
Arantseva, D., & Vodovozova, E. L. (2018) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162018060031 · Cited by 13
Super Molecular-polarization Phenomenon of Poly (ethylene glycol) in Deionized Water
Duan, G., Wang, X., Huang, G., Gong, Y., Li, A., & Yang, X. (2011) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2011.596041 · Cited by 4
Cited by
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
Fulton, M. D., & Najahi-Missaoui, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076615 · Cited by 258
Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine
Cassani, M., Fernandes, S., Pagliari, S., Cavalieri, F., Caruso, F., & Forte, G. (2025) · Advanced Science · doi:10.1002/advs.202409898 · Cited by 48
Yue, N.-N., Xu, H.-M., Xu, J., Zhu, M.-Z., Zhang, Y., Tian, C.-M., Nie, Y.-Q., Yao, J., Liang, Y.-J., Li, D.-F., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s413141 · Cited by 46
Nanomedicine for phage therapy: Encapsulation strategies for enhanced antimicrobial efficacy
Dorta-Gorrín, A., Salgueiriño, V., & García-Hevia, L. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107660 · Cited by 16
Metadata
- Authors
- Zalba, S., ten Hagen, T. L. M., Burgui, C., & Garrido, M. J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 351
- Pages
- 22-36
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W4296794294
- Cited by
- 278
- References
- 198
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.